Pathstone Holdings LLC Has $2.72 Million Stock Holdings in Exponent, Inc. (NASDAQ:EXPO)

Pathstone Holdings LLC boosted its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 7.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 23,606 shares of the business services provider’s stock after purchasing an additional 1,722 shares during the quarter. Pathstone Holdings LLC’s holdings in Exponent were worth $2,721,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Kayne Anderson Rudnick Investment Management LLC increased its holdings in shares of Exponent by 6.5% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after purchasing an additional 284,179 shares during the period. Assenagon Asset Management S.A. bought a new position in Exponent during the 2nd quarter worth $22,050,000. International Assets Investment Management LLC acquired a new position in Exponent in the 3rd quarter valued at $11,261,000. Conestoga Capital Advisors LLC raised its holdings in Exponent by 2.8% in the 2nd quarter. Conestoga Capital Advisors LLC now owns 2,763,260 shares of the business services provider’s stock valued at $262,841,000 after acquiring an additional 75,909 shares in the last quarter. Finally, TimesSquare Capital Management LLC lifted its position in shares of Exponent by 21.1% during the 3rd quarter. TimesSquare Capital Management LLC now owns 280,090 shares of the business services provider’s stock valued at $32,289,000 after acquiring an additional 48,859 shares during the period. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Paul R. Johnston sold 1,300 shares of the company’s stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $95.03, for a total transaction of $123,539.00. Following the completion of the sale, the director now directly owns 59,406 shares in the company, valued at $5,645,352.18. This represents a 2.14 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the transaction, the director now owns 5,871 shares in the company, valued at approximately $565,494.72. This represents a 15.04 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 30,339 shares of company stock worth $3,103,065 over the last three months. Insiders own 2.10% of the company’s stock.

Exponent Stock Up 2.3 %

EXPO opened at $100.30 on Tuesday. Exponent, Inc. has a twelve month low of $68.70 and a twelve month high of $115.75. The stock has a market capitalization of $5.09 billion, a price-to-earnings ratio of 48.45 and a beta of 0.69. The company has a 50-day simple moving average of $106.17 and a 200 day simple moving average of $102.22.

Exponent Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be given a dividend of $0.28 per share. The ex-dividend date of this dividend is Friday, December 6th. This represents a $1.12 annualized dividend and a yield of 1.12%. Exponent’s dividend payout ratio is currently 54.11%.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.